Investigational drug for degenerative diseases of the lumbosacral spine

Trial ID:
IRB-25-8506
Robert K. Eastlack, MD

Inclusion Criteria

Patients must:

  • Have already decided to have spinal fusion surgery
    Be 18-80 years old

Exclusion Criteria

Patients must not:

  • Use nicotine
    Have a BMI over 40
    Be pregnant or nursing

Additional Info

Patients will be randomized (like the flip of a coin) to 1 of 3 groups: Low dose OsteoAdapt, high dose OsteoAdapt, or standard of care surgery.

All patients will have 5 follow-up visits after the surgery. Total study duration is expected to be up to 36 months.

For more information search NCT06154005 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org